Nuvalent, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUVL research report →
About the company
Nuvalent, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering novel therapeutic solutions for individuals battling cancer. The company's pipeline features two prominent drug candidates.
- CEO
- James R. Porter
- IPO
- 2021
- Employees
- 162
- HQ
- Cambridge, MA, US
Price Chart
- Market Cap
- $9.10B
- P/E
- -20.42
- P/S
- 0.00
- P/B
- 8.29
- EV/EBITDA
- -26.74
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -42.78%
- ROIC
- -35.11%
- Revenue
- $0 · 0.00%
- Net Income
- $-425,377,000 · -63.13%
- EPS
- $-5.85 · -48.85%
- Op Income
- $-414,307,000
- FCF YoY
- -48.71%
- 52W High
- $123.80
- 52W Low
- $71.13
- 50D MA
- $108.92
- 200D MA
- $101.64
- Beta
- 1.15
- Avg Volume
- 2.15M
Get TickerSpark's AI analysis on NUVL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | Noci Darlene | other | 5,500 |
| Jun 29, 26 | Noci Darlene | other | 5,500 |
| Jun 29, 26 | Noci Darlene | sell | 5,500 |
| Jun 16, 26 | Flynn James E | other | 3,444 |
| Jun 16, 26 | Wheeler Cameron | other | 3,444 |
| Jun 16, 26 | Srivastava Sapna | other | 3,444 |
| Jun 16, 26 | Squarer Ron | other | 3,444 |
| Jun 16, 26 | Protopapas Anna | other | 3,444 |
| Jun 16, 26 | Oliger Christy J. | other | 3,444 |
| Jun 16, 26 | Meyers Michael L. | other | 3,444 |
Our NUVL coverage
Recent articles, reports, and earnings notes.
No research on NUVL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NUVL report →Similar companies
Peers in the same neighborhood.